Abortion in the United States Dashboard
On June 24, 2022, the Supreme Court overturned Roe v. Wade, eliminating the federal constitutional standard that had protected the right to abortion. Without any federal standard regarding abortion access, states will set their own policies to ban or protect abortion. The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. Be sure to click on the buttons or scroll down to see all the content. It will be updated as new information is available.
-
79% of Abortions Occur Before 10 Weeks
-
Out-of-Pocket Abortion Costs
In 2021, the median costs for people paying out of pocket in the first trimester were $568 for a medication abortion and $625 for a procedural abortion. The Federal Reserve estimates that nationally about one-third of people do not have $400 on hand for unexpected expenses. For low-income people, who are more likely to need abortion care, these costs are often unaffordable.
-
Legal Challenges to the FDA Approval of Medication Abortion Pills
This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA's approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
-
State and Federal Reproductive Rights and Abortion Litigation Tracker
This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.
-
Legal Challenges to State Abortion Bans Since the Dobbs Decision
This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.
-
Abortion at SCOTUS: Dobbs v. Jackson Women’s Health
This issue brief provides background on the legal challenges to the Mississippi law in the context of the Supreme Court abortion precedents, addresses the intersections with the litigation that has arisen from S.B. 8, the Texas 6-week abortion ban, and explains the potential outcomes and how they could impact access to abortion around the country.
-
Availability of Telehealth for Medication Abortion in a Post-Roe United States
Six states, Arizona, Arkansas, Missouri, Louisiana, Texas, and West Virginia, have passed laws specifically banning telehealth for abortion provision. In addition,14 other states have enacted laws that require the clinician providing a medication abortion to be physically present during the procedure, effectively prohibiting the use of telehealth to dispense medication for abortion remotely.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
-
The Availability and Use of Medication Abortion
This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.
-
The Intersection of State and Federal Policies on Access to Medication Abortion Via Telehealth
This brief outlines the intersection of federal policy regarding dispensing medication abortion with state laws regulating the provision of abortion services and mifepristone dispensing via telehealth and considers the implications of the recent FDA change in different states.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
-
Infographic: The Availability and Use of Medication Abortion Care
-
Current Abortion Coverage Restrictions
Several states have enacted private plan restrictions and have also banned abortion coverage from ACA Marketplace plans. Currently, there are 12 states that restrict abortion coverage in private plans and X that ban coverage in any Marketplace plans.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
-
Abortion Decision Renews Questions About Employer Access to Health Information
This Policy Watch takes a look at employers ability to access abortion information when their health plan covers abortion services. With some states criminalizing entities who assist in abortions, employers and providers face legal jeopardy and existing privacy laws such as HIPAA (the Health Insurance Portability and Accountability Act) may be limited in their privacy protections.
-
Employer Assistance with Abortion Related Travel Costs
This Policy Watch gives an overview of employers offering to cover travel expenses for workers who need to go out of state for an abortion in the context of increasing restrictions on abortion around the country. We discuss who is offering these benefits, the implications for workers, and some of the legal and political concerns for employers.
-
After Roe: Options to Address Medicaid Coverage Policy Related to Maternal and Child Health
This policy watch examines the intersection of Medicaid coverage policies with state actions to ban abortion.
-
The Public, Including Women of Childbearing Age, Are Largely Confused About the Legality of Medication Abortion in Their States
More than six months since the Supreme Court issued its Dobbs decision which overturned Roe v. Wade, the January 2023 KFF Health Tracking Poll finds widespread public confusion around the use of mifepristone, the medication abortion pill, and the legality of the medication in their state.
-
The Vast Majority of Voters Oppose Laws That Would Prohibit Abortion in Cases of Rape and Incest
According to our October 2022 tracking poll, more than eight in ten voters (83%) in states with full abortion bans say they oppose laws prohibiting abortion even in cases of rape and incest – which is currently the case in most of these states with full abortion bans.
-
The Hyde Amendment and Coverage for Abortion Services
This brief details the federal programs that are affected by the Hyde Amendment and laws and regulations that have a similar goal, provides estimates on the share of women insured by Medicaid affected by the law, reviews the impact of the law on their access to abortion services, and discusses the potential effect if the law were to be repealed.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
-
Medicaid Postpartum Coverage Extension Tracker
This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a (State Plan Amendment) SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
-
Pregnancy-Related Mortality (per 100,000 births) by Race/Ethnicity, 2007-2016
Black and American Indian/Alaska Native people are more likely to die while pregnant or within a year of the end of pregnancy compared to White people. Limited access or bans on abortion may widen existing disparities in maternal and infant health.
-
Racial/Ethnic Distribution of Women Ages 18-49 Living in States with Trigger or Pre-Roe Bans, 2019
Over four in ten of women between ages 18-49 living in states where abortion has become or will likely become illegal are women of color, who may face disproportionate barriers to accessing abortions if they have to travel out-of-state.
-
Understanding Pregnancy Loss in the Context of Abortion Restrictions and Fetal Harm Laws
This brief examines how policies aimed at limiting abortion may have negative consequences on people experiencing pregnancy loss.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
-
OBGYNs and the Provision of Sexual and Reproductive Health Care: Key Findings from a National Survey
This report highlights key findings from the 2020 KFF National Physician Survey on Reproductive Health that asked a nationally representative sample of OBGYNs practicing in the United States about a wide range of issues, including their provision of contraception, abortion, and STI care.
**This analysis was conducted prior to June 24, 2022, when the Supreme Court overturned Roe v. Wade and eliminated the federal constitutional right to abortion.**
Latest Resources From KFF
-
States with Gestational Limits for Abortion
-
Mandatory Waiting Periods for Women Seeking Abortions
-
The Availability and Use of Medication Abortion
-
New KFF Survey Finds Abortion Remains Key Issue for Voters with Democrats Holding a Sizeable Edge over Republicans; A Third of Women Say They’ll Only Vote for Someone Who Shares Their Views
-
KFF Health Tracking Poll May 2023: Health Care in the 2024 Election and in the Courts
-
What Are the Exceptions to State Abortion Bans?